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ment because of the increased incidence of failures in those
patients. The primary reasons for the failures observed were
wear, loosening and mechanical failures. Recent advances in
designs, materials, surgical technique and instrumentation has
dramatically improved these procedures. For example, alterna-
tive bearing surfaces such as highly crossed linked polyethylene
and enhanced ﬁxation methods using improved porous surfaced
implants have signiﬁcantly reduced wear, bone loss from osteoly-
sis and implant loosening. Minimally invasive surgical procedures
have accelerated the rehabilitation of patients and sophisticated
instrumentation provides excellent restoration of anatomy.
Results: Using these contemporary design materials and sur-
gical techniques implant survival rates of 98-99% at ten years
and 90-95% at 15-20 years can be expected following total hip
or knee replacement even in younger, active patients. By con-
trast, total ankle replacement was until recently a procedure of
historical interest because of the high rate of loosening and
mechanical failure. Early results of total ankle replacement with
contemporary designs have been encouraging, but current rec-
ommendations are for the procedure to be performed for low
demand patients by surgeons who have completed special train-
ing for the technique.
Conclusions: Future improvement in designs and materials of
joint replacements will continue to enhance patient outcomes
and functional long-term implant survival.
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Shoulder replacement using an ivory prosthesis was ﬁrst
recorded in 1890 by a Romanian surgeon Theristocles Gluck
who was born in 1853. However, Emile Pean is more widely
recognized for a shoulder replacement, made of rubber and plat-
inum, he performed in Paris in 1893 to treat the late effects of
tuberculosis.
Despite these early pioneering operations it was not until
the 1950s that signiﬁcant advances were made in shoulder
arthroplasty, which is currently used today in the treatment
of osteoarthritis, rheumatoid arthritis, cuff tear arthropathy, os-
teonecrosis, instability arthritis and post infective arthropathy.
In Europe in the 1950s tumour prostheses were developed to
replace the resected proximal humerus, but as the rotator cuff
was usually sacriﬁced during these procedures this resulted in
anterosuperior subluxation of the implant. Constrained joints like
hip replacements were therefore developed to stabilize the artic-
ulation, but these lateralized the centre of rotation of the shoulder
resulting in early loosening. Reversing the ball and socket ge-
ometry, i.e. with the ball on the glenoid and the socket on the
humerus, was attempted in a variety of designs, but all failed
because the centre of rotation remained lateral to the scapula.
This resulted in limitation of movement and considerable torque
being transmitted to the glenoid component causing loosening.
In the 1970s Paul Grammont redesigned the reverse geometry
prosthesis (Delta) for the use in cuff arthropathy. He used a large
glenoid hemisphere with no neck and a socket on the humeral
side which inclined almost horizontally and covered less than half
of the hemisphere. This design medialises the centre of rotation
and therefore minimises the torque transmitted to the glenoid
component. This implant allows, in the absence of the cuff, the
anterior and posterior deltoid ﬁbres to act as abductors of the
shoulder. It also restores the tension in the deltoid by lowering the
humerus with respect to the acromion, thus allowing the deltoid
to function without the rotator cuff. Although this can therefore
restore active elevation rotation still remains limited. The results
of this implant in the treatment of rotator cuff arthropathy are a
signiﬁcant improvement on the alternatives available at 5 - 10
years although it is still recommended for older patients (over
70 years) with low functional demands. It has also been used in
rheumatoid arthritis, where cuff function is often poor, in revision
surgery, in tumour surgery and to treat difﬁcult proximal humeral
fractures, all of which have far less predictable results.
Charles Neer working in the 1950s in New York developed
proximal humeral head prosthesis for the management of frac-
tures, but later in 1972 developed a glenoid component so that
glenohumeral arthritis could be treated by total shoulder replace-
ment. The Neer humeral prosthesis was a cemented monoblock
design, but as with hip arthroplasty modular designs were de-
veloped to allow various stem/head combinations to be used.
In the 1990s, with the recognition of the anatomical variation
of the proximal humerus, particularly with respect of offset and
version of the humeral head to the humeral shaft, third gen-
eration modular prostheses have been developed. These allow
the surgeon to replicate the patients’ proximal humeral anatomy
using these stemmed implants which were also developed in
uncemented forms. There are now many papers reporting the
results of stemmed total shoulder and hemiarthroplasties in the
treatment of both inﬂammatory and degenerative disease.
Surface replacement of the humeral head was developed ini-
tially in the late 1970s both in cemented and uncemented forms.
These types of implants can be used in glenohumeral arthritis in-
cluding osteonecrosis providing there is sufﬁcient humeral head
remaining - about 60% of normal is required. Such implants have
advantages over stemmed prostheses whilst reported results for
osteoarthritis, rheumatoid arthritis and osteonecrosis are cer-
tainly equivalent. Humeral implants can be reliably centered on
the patients’ humeral head and therefore negate the problems
of variable inclination, version and posterior offset. Surface re-
placement requires minimal bone resection which is particularly
important in the younger patient. Stems produce a stress riser
at the tip of the prosthesis which may result in periprostheic
fracture. 30% of unsatisfactory results post stemmed shoulder
replacements are due to component malalignment, which could
be prevented by the use of surface arthroplasty. Revision surgery
for component malposition or for infection is very difﬁcult both
when the stem is cemented and uncemented as stem extraction
can be very destructive to the proximal humerus. If complica-
tions occur requiring revision then certainly revising a surface
replacement is much less demanding.
One of the most debated topics in shoulder surgery is whether to
do a hemiarthroplasty or total replacement. There are advocates
for both. With stemmed implants there seems to be an advantage
in osteoarthritis for total replacement as the early pain relief
and function is improved and the revision rate from hemi to
total for glenoid erosion exceeds the rate of glenoid component
revision. This is not true in surface replacement where results of
hemi and total are comparable in osteoarthritis and rheumatoid.
The rationale for a hemiarthroplasty is to avoid the insertion
of polyethylene, which if worn produces debris which in turn
causes the eventual loosening and failure of the joint. This is
also the reported cause of failure in the reversed geometry Delta
prosthesis where impingement of the humeral component on the
scapula neck produces notching and wear of the polyethylene.
The problem of polyethylene debris has led some to recommend
drilling the glenoid surface to encourage ﬁbrocartilage formation
and others to use biolological resurfacing.
In conclusion there is now a choice of prostheses designed to
manage particular pathologies. A stemmed prosthesis is required
for fracture reconstruction as it was initially designed. A reverse
prosthesis in cuff arthropathy, for which it was designed, will in
an elderly individual achieve a better functional result than the
alternative stemmed or surface implant. When the pathology is
conﬁned to the articular surface it would therefore appear rational
to use a surface replacement as it was speciﬁcally designed for
the use in arthritis. The problem of the glenoid and potential
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polyethylene wear is unresolved but as yet the option of biological
resurfacing is unproven and further research is required.
AMBULATORY MECHANICS IN THE INITIATION AND
PROGRESSION OF KNEE OSTEOARTHRITIS
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Osteoarthritis (OA) may be best regarded as a group of joint
disorders with different aetiologies but a common pathophysio-
logical process that alters articular anatomy and function. At the
knee, abnormal forces related to weight-bearing are theorized to
trigger the cascade of biological events that result in osteoarthri-
tis. Indeed, ambulatory mechanics have shown great promise in
relating to the development and radiographic progression of knee
OA. However, the mechanisms underlying knee OA and the role
of biomechanics in the progression of disability remain unclear.
Methods required to measure the contact forces acting upon the
knee joint surfaces are invasive. As a result, the actual loads
borne by the tibial plateau in vivo have been documented in only
one person, using an instrumented implant. More commonly, the
forces and torques acting at the knee are estimated, based on
Newton’s laws, from measures of joint motion, ground reaction
forces and inertial properties. Of the thousands of data points
produced by gait analysis, the peak knee adduction moment has
received the most attention in knee OA research. This moment
describes the maximum torque tending to push the tibia medially
upon the femur and reﬂects the distribution of loading between
the medial and lateral knee compartments. The validity of this
variable has been supported by mathematical modeling, bone
density distribution, cartilage thickness and direct measurement
of the contact forces at the knee.
Although it is often assumed that abnormal gait dynamics are re-
sponsible for inciting osteoarthritic changes at the knee, evidence
to support this hypothesis in humans is only recently emerging.
Retrospective longitudinal studies spanning 3-10 years implicate
the peak knee adduction moment in the development of chronic
knee pain or radiographic knee OA. A much greater propor-
tion of OA knee biomechanical research has been dedicated to
radiographic disease progression. Strong evidence shows that
radiographic disease progression is facilitated by the adduction
moment during gait.
However, at least two critical areas require greater attention to
yield insight into the pathomechanics of knee OA. First, the peak
adduction moment has proven useful but there is likely much
more information embedded in gait data that has not been fully
exploited. Innovative methods are required to explore the mul-
tidimensional nature of gait and distinguish between features
that are relevant to mechanisms of pathology, or of compen-
sation. Biomechanists continue to develop more sophisticated
approaches to gait data collection, reduction and analysis in
knee OA to address this issue.
Second, very little work has related ambulatory mechanics to
measures of disease progression that are meaningful to people
with knee OA. The relationships between radiographic measures
and disability, mobility limitations or symptoms are poor. Can
biomechanical quantiﬁcations of joint and muscle function pro-
vide meaningful answers regarding how to alleviate the disability
experienced by people with knee OA? Studying the interactions
between traditional biomechanical measures and other aspects
of health, including patient experience, will improve the clinical
relevance of gait analysis. Although non-traditional, these inte-
grated approaches will provide greater insight into the role of gait
biomechanics in knee OA initiation and disability progression.
MOVEMENT ANALYSIS IN ARTHRITIS RESEARCH: IS
KNOWLEDGE BEING TRANSLATED INTO PRACTICE?
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Although a clear picture of the role mechanical factors in the
progression of OA has yet to emerge, the evidence suggests
there are a number of biomechanical variables that may be
potentially important in terms of better understanding and mon-
itoring disease progression of knee osteoarthritis (OA). A short
list would include knee ﬂexion-extension range during gait (or
dynamic ROM), knee ﬂexion strength, varus-valgus alignment
and knee adduction moment. Yet little is known about how to
optimally modify these variables to improve function. The neuro-
muscular mechanisms that underlie movement abnormalities in
people with knee OA are not well understood, and the secondary
consequences of these biomechanical alterations has received
little attention. Several studies of gait in knee OA patients show
abnormalities in joint kinetics at the hip and low-back, suggest-
ing that the mechanisms at work to protect the painful knee
may require altered hip and upper body movement and loading
patterns.
Neural adaptation to altered muscle-joint interactions may be an
important factor in the progression of the knee OA. These adap-
tations have been reported to protect the damaged and painful
joint, but have also been implicated in further exacerbating joint
damage. It is plausible that both mechanisms exist (protective
and destructive) but at different stages in the course of the dis-
ease, and/or these mechanisms are highly variable depending
on the individual (such as gender, health, lifestyle, etc.). Hence a
number of questions arise: Is there a stage in the disease where
neural adaptation modiﬁes muscle ﬁring patterns to protect the
joint while maintaining a functional gait? Does this adaptation
eventually fail, resulting in varus-valgus abnormality and acceler-
ated joint damage? Is there therapeutic value in training patients
to use these protective adaptations? Can these adaptations be
trained in those not predisposed to acquire them naturally? Do
these adaptations have consequences to the health of other
joints?
Inclusion of biomechanical analyses in clinical trials and longitu-
dinal studies would greatly enhance our ability to answer some
of these questions. Unfortunately, the motion analysis research
required to answer these questions is expensive and can be time
consuming for both the clinician and the patient. Furthermore,
the vast majority of human movement research in knee OA takes
place in a research lab. As such, few clinical researchers are
actively involved and invested in biomechanical measurement
techniques, reducing the capacity to translate this information
into clinically relevant actions.
Although many questions need to be answered before the role of
mechanical factors in knee OA is elucidated, few of these ques-
tions will get answered until some of the barriers to knowledge
translation are identiﬁed and eliminated. While a better under-
standing of the mechanisms of movement abnormality is indeed
needed, lack of clinical trials and longitudinal studies that involve
measurement of biomechanical variables, and a lack of capacity
(facilities, personnel, equipment, etc.) for capturing, analyzing
and interpreting meaningful clinical measurements, may repre-
sent modiﬁable barriers that, if overcome, could lead to a better
understanding of the mechanisms of movement abnormality, and
more effective therapies for avoiding disablement, due to knee
OA and other musculoskeletal diseases.
